Skip to main content

Evidence-Based Supplement Research

Evidence-Based Supplement Research

Lactobacillus reuteri DSM 17938 and Reduced Infant Formula Switching

Doses used in studies

drops/day: 5 (median 5, IQR 5–5) — 1 study

Time to effect

Median: 2.8 months · IQR 2.8 months–2.8 months · Range 2.8 months–2.8 months — Reported in 1 of 1 study

1 of 1 paper

Preventive effects of oral probiotic on infantile colic: a prospective, randomised, blinded, controlled trial using Lactobacillus reuteri DSM 17938.
- 2015-01-01
- RCT · n = 138
- Beneficial microbes 6(3)
- - F Savino
  - S Ceratto
  - E Poggi
  - M E Cartosio
  - L Cordero di Montezemolo
  - A Giannattasio
- PubMed: 25488262
- DOI: 10.3920/bm2014.0090
4 Insights on
- Reduced Infant Formula Switching
- High evidence
- Large Human Trial
- Rigorous Journal
- Infants
the relative risk was 0.37 (95% CI=0.17-0.80) for the administration of infant formula
Effect
Beneficial
Effect size
Large
Significant
Yes
Dose
five drops containing Lactobacillus reuteri DSM 17938 (10^8 cfu) with 400 IU of vitamin D3 daily